PIVOTAL BIOVENTURE PARTNERS
Pivotal bioVenture Partners is a $300 million life sciences venture capital fund established in 2017. They invest in privately held North American and European companies focused on innovative therapeutic products and platforms to address major unmet medical needs. They invest at all stages in a companyโs evolution, from company creation through mid and late stage clinical development. Their team brings diverse experience in venture capital, company building, and drug discovery and development to the table in working with entrepreneurs to advance their businesses.
PIVOTAL BIOVENTURE PARTNERS
Industry:
Biotechnology Venture Capital
Founded:
2017-01-04
Status:
Active
Contact:
415-697-1002
Email Addresses:
[email protected]
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS Facebook Sharer GoDaddy Amazon SES Barracuda Networks KnowBe4
Current Employees Featured
Heather Preston
Heather Preston Managing Partner @ Pivotal bioVenture Partners Managing Partner 2018-07-01
Vincent Cheung
Vincent Cheung Managing Partner @ Pivotal bioVenture Partners Managing Partner
Karoly Nikolich
Karoly Nikolich Venture Partner @ Pivotal bioVenture Partners Venture Partner
Ash Khanna
Ash Khanna Venture Partner @ Pivotal bioVenture Partners Venture Partner 2017-09-01
Karoly Nikolich
Karoly Nikolich Venture Partner @ Pivotal bioVenture Partners Venture Partner 2017-01-01
Founder
Tracy Saxton
Vincent Cheung
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-02-23 | Plexium | Pivotal bioVenture Partners investment in Series B - Plexium | 102 M USD |
2022-02-10 | Arkuda Therapeutics | Pivotal bioVenture Partners investment in Series B - Arkuda Therapeutics | 64 M USD |
2021-11-30 | SanReno Therapeutics | Pivotal bioVenture Partners investment in Funding Round - SanReno Therapeutics | 40 M USD |
2021-11-29 | HotSpot Therapeutics | Pivotal bioVenture Partners investment in Series C - HotSpot Therapeutics | 100 M USD |
2021-09-09 | Evommune | Pivotal bioVenture Partners investment in Series A - Evommune | 83 M USD |
2021-09-09 | Obsidian Therapeutics | Pivotal bioVenture Partners investment in Series B - Obsidian Therapeutics | 115 M USD |
2021-08-18 | Vigil Neuroscience | Pivotal bioVenture Partners investment in Series B - Vigil Neuroscience | 90 M USD |
2021-05-04 | Oculis | Pivotal bioVenture Partners investment in Series C - Oculis | 57 M USD |
2021-04-20 | Exscientia | Pivotal bioVenture Partners investment in Series D - Exscientia | 225 M USD |
2021-01-19 | Plexium | Pivotal bioVenture Partners investment in Series A - Plexium | 35 M USD |